ATAI (atai Life Sciences NV) Bathi resik saben siji saham sajrone rolas wulan pungkasan

atai Life Sciences NV (ATAI) - logo korporat

Atai Life Sciences N.V. (ATAI) is recognized as a pioneer in psychedelic therapy, which provides the company with a high level of investor confidence. The annual volatility of net income per share TTM clearly demonstrates the business dynamics, where the value -171.80 describes the current level. Investments in unique molecules create a foundation for future revenues, while capital management efficiency is supported by a decentralized research model.

Bathi resik saben saham (EPS TTM) atai.life (ATAI): kanggo periode 11.02.2024 - 26.09.2026

atai - rincian analitis lan metrik utama (ATAI)

Pambiji fundamental:atai Life Sciences (ATAI)
Barang utama atai Life Sciences Corp

Year-over-year EPS (TTM) growth reflects the earnings per share dynamics over a rolling twelve-month period, allowing for an assessment of the business's actual capitalization efficiency. By analyzing the annual EPS TTM growth rate, an investor can see the impact of heavy R&D expenditures and FDA regulatory pressure on the net income of Atai Life Sciences N.V. (ATAI), where any fluctuations in this metric depend directly on the success of costly clinical trials.